FOCINVEZ 150 mg in 50 mL Injection
RxNorm 2664071
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2664071 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: FOCINVEZ 150 mg in 50 mL Injection.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SYPrescribable
Synonym (SY):
50 mL Focinvez 3 mg/ML Injection
(Atom ID: 12850479)
SBDPrescribable
Semantic Branded Drug (SBD):
50 mL fosaprepitant 3 mg/ML Injection [Focinvez]
(Atom ID: 12850478)
PSNPrescribable
Prescribable Name (PSN):
FOCINVEZ 150 mg in 50 mL Injection
(Atom ID: 12850482)
SYPrescribable
Synonym (SY):
Focinvez 150 mg per 50 mL Injection
(Atom ID: 12850483)
Patient Education
Aprepitant/Fosaprepitant Injection
Aprepitant injection and fosaprepitant injection are used along with other medications to prevent nausea and vomiting in adults that may occur within 24 hours or several days after receiving certain cancer chemotherapy treatments. Fosaprepitant injection can also be used in children 6 months of age and older. Aprepitant and fosaprepitant injections are not used to treat nausea and vomiting that you already have. Aprepitant and fosaprepitant injections are in a class of medications called antiemetics. They work by blocking the action of neurokinin, a natural substance in the brain that causes nausea and vomiting.
[Learn More]
* Please review the disclaimer below.